The safety profile of loracarbef: clinical trials in respiratory, skin, and urinary tract infections
- 1 June 1992
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 92 (6) , S20-S25
- https://doi.org/10.1016/0002-9343(92)90603-9
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Antibiotic therapy for urinary tract infectionsThe American Journal of Medicine, 1992
- Loracarbef (LY163892) versus cefaclor and norfloxacin in the treatment of uncomplicated pyelonephritisThe American Journal of Medicine, 1992
- Loracarbef (LY163892) versus cefaclor in the treatment of bacterial skin and skin-structure infections in an adult populationThe American Journal of Medicine, 1992
- Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult populationThe American Journal of Medicine, 1992
- Acute bacterial maxillary sinusitis: Results of U.S. and European comparative therapy trialsThe American Journal of Medicine, 1992
- Efficacy and safety of loracarbef in the treatment of pneumoniaThe American Journal of Medicine, 1992
- Loracarbef (LY163892) in the treatment of acute exacerbations of chronic bronchitis: Results of U.S. and European comparative clinical trialsThe American Journal of Medicine, 1992
- Acute bronchitis: Results of U.S. and European trials of antibiotic therapyThe American Journal of Medicine, 1992
- In vitro activity of loracarbef and effects of susceptibility test methodsThe American Journal of Medicine, 1992
- Pharmacokinetic profile of loracarbefThe American Journal of Medicine, 1992